Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
ZNF509
is unique among POK family proteins in that four isoforms are generated by alternative splicing. Short
ZNF509
(ZNF509S1, -S2 and -S3) isoforms contain one or two out of the seven zinc-fingers contained in long
ZNF509
(ZNF509L). Here, we investigated the functions of
ZNF509
isoforms in response to DNA damage, showing isoforms to be induced by
p53
. Intriguingly, to inhibit proliferation of HCT116 and HEK293 cells, we found that ZNF509L activates p21/CDKN1A transcription, while ZNF509S1 induces RB. ZNF509L binds to the p21/CDKN1A promoter either alone or by interacting with MIZ-1 to recruit the co-activator p300 to activate p21/CDKN1A transcription. In contrast, ZNF509S1 binds to the distal RB promoter to interact and interfere with the MIZF repressor, resulting in derepression and transcription of RB. Immunohistochemical analysis revealed that
ZNF509
is highly expressed in normal epithelial cells, but was completely repressed in tumor tissues of the colon, lung and skin, indicating a possible role as a tumor suppressor.
...
PMID:Two ZNF509 (ZBTB49) isoforms induce cell-cycle arrest by activating transcription of p21/CDKN1A and RB upon exposure to genotoxic stress. 2524 46
Expression of the POK family protein ZNF509L, and -its S1 isoform, is induced by
p53
upon exposure to genotoxic stress. Due to alternative splicing of the
ZNF509
primary transcript, ZNF509S1 lacks the 6 zinc-fingers and C-terminus of ZNF509L, resulting in only one zinc-finger. ZNF509L and -S1 inhibit cell proliferation by activating p21/CDKN1A and RB transcription, respectively. When cells are exposed to severe DNA damage,
p53
activates PUMA (
p53
-upregulated modulator of apoptosis) transcription. Interestingly, apoptosis due to transcriptional activation of PUMA by
p53
is attenuated by ZNF509S1. Thus we investigated the molecular mechanism(s) underlying the transcriptional attenuation and anti-apoptotic effects of ZNF509S1. We show that ZNF509S1 modulation of
p53
activity is important in PUMA gene transcription by modulating post-translational modification of
p53
by p300. ZNF509S1 directly interacts with
p53
and inhibits p300-mediated acetylation of
p53
lysine K382, with deacetylation of
p53
K382 leading to decreased DNA binding at the
p53
response element 1 of the PUMA promoter. ZNF509S1 may play a role not only in cell cycle arrest, by activating RB expression, but also in rescuing cells from apoptotic death by repressing PUMA expression in cells exposed to severe DNA damage.
...
PMID:ZNF509S1 downregulates PUMA by inhibiting p53K382 acetylation and p53-DNA binding. 2875 84